Evaluation of follicle-stimulating hormone versus anti-Müllerian hormone in polycystic ovary syndrome: clinical implications
Background. Polycystic Ovary Syndrome (PCOS) is a hormonal disorder affecting women of reproductive age. Alarmingly, there is a significant diagnostic gap, with about 75 % of women in hospital settings unknowingly having PCOS due to inconsistent diagnostic criteria. The manifestations of PCOS are m...
Saved in:
| Main Author: | Hamza Hameed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Львівський національний університет імені Івана Франка
2024-12-01
|
| Series: | Біологічні студії |
| Subjects: | |
| Online Access: | http://publications.lnu.edu.ua/journals/index.php/biology/article/view/5620 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of anti mullerian hormone and follicle stimulating hormone discordance on oocyte quality and live birth rates
by: Seray Kaya, et al.
Published: (2024-04-01) -
Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review
by: Duru Shah, et al.
Published: (2024-01-01) -
Role of Inhibin B and Ratio of Luteinizing: Follicle-Stimulating Hormones in Phenotyping Polycystic Ovarian Syndrome
by: Zainab G. Falh, et al.
Published: (2024-12-01) -
Comparison of two different anti-mullerian hormone measurement methods and evaluation of anti-mullerian hormone in polycystic ovary syndrome
by: Gök Gamze, et al.
Published: (2025-05-01) -
Role of follicle-stimulating hormone receptor polymorphism in predicting ovarian response to letrozole in women with polycystic ovary syndrome during ovulation induction
by: Xiuxian Zhu, et al.
Published: (2025-06-01)